PHAT Initiates Coverage On Leerink Partners -- Rating Set to Market Perform
gurufocus.com · 2026-09-09
Phathom Pharmaceuticals: Analyst Coverage Initiation and Valuation Insights On October 17, 2023, Phathom Pharmaceuticals (PHAT) received a new analyst rating
Read the full story at gurufocus.com →
Is PHAT undervalued? See TickrTrends' fair value analysis →